Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Quality & sourcing matter
The final product is urine which the body excretes
Phase 1b/2a results (published in The Lancet, 2025): - In 125 adults with overweight or obesity, the subcutaneous 20 mg dose achieved 22.0% absolute weight loss (23.9% placebo-adjusted)
Minimally invasive alternatives exist for patients with mild laxity, including radiofrequency-assisted liposuction and energy-based skin tightening devices
BPC-157 can complement other wellness therapies, including hormone treatments, physical therapy, and additional peptide regimens
No subscription, no auto-billing
US$ 21.79
US$ 24.05
US$ 22.30
US$ 28.34
US$ 23.30
US$ 27.62
